Abiopharma

News list

📋 STEPHEN PAKOLA (Officer) plans to sell 35K shares of REGENXBIO Inc. (at $10.55 each, total $368K) Filed: May 11, 2026 | ID: 004334

Full text

News bot May 11, 2026, 8:36 p.m.
📋 Form 144 Filing: STEPHEN PAKOLA

Company: REGENXBIO Inc.

Filing Date: 2026-05-11

Relationship: Officer
Planned Sale Details:
- Security: Common
- Shares to be Sold: 34,917
- Price per Share: $10.55
- Total Value: $368,374.35
- Planned Sale Date: 2026-05-11
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-37553
- Issuer Contact Phone: 2405528181
- Issuer Address: 9804 Medical Center Drive, Rockville, MD, 20850
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 51612984.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 1
- Remarks: The securities to be sold were acquired upon the vesting of restricted stock units during the period of 1/1/2026 through 2/1/2026.